These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10210713

  • 1. Left ventricular hypertrophy in hypertension.
    Dunn FG, Pfeffer MA.
    N Engl J Med; 1999 Apr 22; 340(16):1279-80. PubMed ID: 10210713
    [No Abstract] [Full Text] [Related]

  • 2. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D.
    N Engl J Med; 1999 Apr 22; 340(16):1221-7. PubMed ID: 10210704
    [Abstract] [Full Text] [Related]

  • 3. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G.
    Ann Cardiol Angeiol (Paris); 1998 Feb 22; 47(2):86-90. PubMed ID: 9772934
    [Abstract] [Full Text] [Related]

  • 4. [Left ventricular myocardial hypertrophy in arterial hypertension: clinical significance, diagnosis, effects of antihypertensive drugs].
    Martynov AI, Ostroumova OD, Mataev VI, Gedgafpva SIu, Il'ina SV.
    Klin Med (Mosk); 2000 Feb 22; 78(10):10-7. PubMed ID: 11220891
    [No Abstract] [Full Text] [Related]

  • 5. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE.
    J Cardiovasc Pharmacol; 1992 Feb 22; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [Abstract] [Full Text] [Related]

  • 6. Should physicians aggressively treat prehypertension?
    Garrett SL.
    Am J Med; 2009 May 22; 122(5):e19; author reply e21. PubMed ID: 19375537
    [No Abstract] [Full Text] [Related]

  • 7. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F, García González M, Domínguez Rodríguez A, Barragán Acea A, Miralles Ibarra JM, Lacalzada Almeida J, de Armas Trujillo D.
    Rev Esp Cardiol; 1997 May 22; 50 Suppl 4():74-6. PubMed ID: 9411592
    [Abstract] [Full Text] [Related]

  • 8. The effect of alpha-blockers on cardiac function.
    Antani JA.
    J Assoc Physicians India; 1998 May 22; Suppl 1():11-4. PubMed ID: 11229103
    [No Abstract] [Full Text] [Related]

  • 9. [Hypertensive heart disease associated with heart failure].
    Ishikawa J, Shimada K, Kario K.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():531-8. PubMed ID: 17571430
    [No Abstract] [Full Text] [Related]

  • 10. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ.
    Am J Hypertens; 1999 Jan 28; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract] [Full Text] [Related]

  • 11. [Cardiac diagnostic in hypertension].
    Ukena C, Mahfoud F, Böhm M.
    MMW Fortschr Med; 2014 Jun 26; 156(12):51-3. PubMed ID: 25369687
    [No Abstract] [Full Text] [Related]

  • 12. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
    Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS.
    J Hum Hypertens; 2006 Jun 26; 20(6):460-4. PubMed ID: 16572193
    [No Abstract] [Full Text] [Related]

  • 13. [Significance of left ventricular hypertrophy in primary hypertension and therapeutic modification by antihypertensive drugs].
    Schiemann AL, Stimpel M.
    Praxis (Bern 1994); 1997 Jul 02; 86(27-28):1101-6. PubMed ID: 9324718
    [Abstract] [Full Text] [Related]

  • 14. Slower heart rates for healthy hearts: time to redefine tachycardia?
    Gopinathannair R, Sullivan RM, Olshansky B.
    Circ Arrhythm Electrophysiol; 2008 Dec 02; 1(5):321-3. PubMed ID: 19808425
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.
    Circ Arrhythm Electrophysiol; 2008 Dec 02; 1(5):337-43. PubMed ID: 19808428
    [Abstract] [Full Text] [Related]

  • 16. Ventricular repolarization in hypertension: beyond Bazett.
    Passino C, Emdin M.
    Am J Hypertens; 2008 Jan 02; 21(1):9. PubMed ID: 18091736
    [No Abstract] [Full Text] [Related]

  • 17. [Impact of arterial hypertension on the heart].
    Herpin D.
    Rev Prat; 1999 Mar 01; 49(5):491-4. PubMed ID: 10358398
    [Abstract] [Full Text] [Related]

  • 18. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J.
    Arch Cardiol Mex; 2002 Mar 01; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Assessment of preclinical target organ damage in hypertension: left ventricular hypertrophy.
    Rosei EA, 1999 WHO/ISH Hypertension Guidelines.
    J Hypertens; 2002 Jan 01; 20(1):156-8. PubMed ID: 11791040
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.